A single bite or wildlife exposure can turn “vaccinated” into a complicated question fast, especially when the animal is a zoological species, a wildlife rehabilitation patient, or any non-traditional mammal that does not have a licensed rabies vaccine label. We sit down with Dr. Ryan Wallace, who leads the rabies program at the US Centers for Disease Control and Prevention, to unpack what clinicians and public health teams can lean on when the rules feel vague and the consequences are real.
We walk through what the research shows about serologic response after extra-label rabies vaccination across many mammalian species, including how often animals reach protective antibody titers after a primary dose and where responses can be lower in very large species or very small species. Ryan also explains why antibody titers naturally decline over time, what “boostability” means in practical terms, and why a strong anamnestic response after a booster can be the signal decision-makers need when assessing risk after exposure.
We also tackle the questions you hear in the exam room: “Why not just titer-check every animal?” and “Does my indoor cat really need rabies vaccination?” The answer involves cost, exposure recognition, and one word that changes everything for indoor pets: bats. If you work in zoo veterinary medicine, wildlife rehabilitation, shelter medicine, or small animal practice, this is a grounded look at evidence that may help prevent unnecessary euthanasia while protecting people and animals. Subscribe, share this with a colleague who fields rabies calls, and leave a review on Apple Podcasts or wherever you listen.
Podden och tillhörande omslagsbild på den här sidan tillhör
AVMA Journals. Innehållet i podden är skapat av AVMA Journals och inte av,
eller tillsammans med, Poddtoppen.
